Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Synergy between EphA2-ILs-DTXp, a novel EphA2 targeted nanoliposomal taxane, and PD-1 inhibitors in preclinical tumor models.

Kamoun WS, Dugast AS, Suchy JJ, Grabow S, Fulton RB, Sampson JF, Luus L, Santiago M, Koshkaryev A, Sun G, Askoxylakis V, Tam E, Huang ZR, Drummond DC, Sawyer AJ.

Mol Cancer Ther. 2019 Oct 9. pii: molcanther.0414.2019. doi: 10.1158/1535-7163.MCT-19-0414. [Epub ahead of print]

PMID:
31597714
2.

Antibody-mediated targeting of TNFR2 activates CD8+ T cells in mice and promotes antitumor immunity.

Tam EM, Fulton RB, Sampson JF, Muda M, Camblin A, Richards J, Koshkaryev A, Tang J, Kurella V, Jiao Y, Xu L, Zhang K, Kohli N, Luus L, Hutto E, Kumar S, Lulo J, Paragas V, Wong C, Suchy J, Grabow S, Dugast AS, Zhang H, Depis F, Feau S, Jakubowski A, Qiao W, Craig G, Razlog M, Qiu J, Zhou Y, Marks JD, Croft M, Drummond DC, Raue A.

Sci Transl Med. 2019 Oct 2;11(512). pii: eaax0720. doi: 10.1126/scitranslmed.aax0720.

PMID:
31578241
3.

Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse models.

Kamoun WS, Kirpotin DB, Huang ZR, Tipparaju SK, Noble CO, Hayes ME, Luus L, Koshkaryev A, Kim J, Olivier K, Kornaga T, Oyama S, Askoxylakis V, Pien C, Kuesters G, Dumont N, Lugovskoy AA, Schihl SA, Wilton JH, Geddie ML, Suchy J, Grabow S, Kohli N, Reynolds CP, Blaydes R, Zhou Y, Sawyer AJ, Marks JD, Drummond DC.

Nat Biomed Eng. 2019 Apr;3(4):264-280. doi: 10.1038/s41551-019-0385-4. Epub 2019 Apr 5.

PMID:
30952988
4.

Preparation for Endurance Competitions at Altitude: Physiological, Psychological, Dietary and Coaching Aspects. A Narrative Review.

Burtscher M, Niedermeier M, Burtscher J, Pesta D, Suchy J, Strasser B.

Front Physiol. 2018 Oct 29;9:1504. doi: 10.3389/fphys.2018.01504. eCollection 2018. Review.

5.

NCAN Cross-Disorder Risk Variant Is Associated With Limbic Gray Matter Deficits in Healthy Subjects and Major Depression.

Dannlowski U, Kugel H, Grotegerd D, Redlich R, Suchy J, Opel N, Suslow T, Konrad C, Ohrmann P, Bauer J, Kircher T, Krug A, Jansen A, Baune BT, Heindel W, Domschke K, Forstner AJ, Nöthen MM, Treutlein J, Arolt V, Hohoff C, Rietschel M, Witt SH.

Neuropsychopharmacology. 2015 Oct;40(11):2510-6. doi: 10.1038/npp.2015.86. Epub 2015 Mar 24.

6.

Cumulative effects of genetic markers and the detection of advanced colorectal neoplasias by population screening.

Kurlapska A, Serrano-Fernández P, Baszuk P, Gupta S, Starzyńska T, Małecka-Panas E, Dabrowski A, Dębniak T, Kurzawski G, Suchy J, Rogoza-Mateja W, Scott RJ, Lubiński J.

Clin Genet. 2015 Sep;88(3):234-40. doi: 10.1111/cge.12481. Epub 2014 Oct 30.

PMID:
25117299
7.

Lynch syndrome mutations shared by the Baltic States and Poland.

Dymerska D, Kurzawski G, Suchy J, Roomere H, Toome K, Metspalu A, Janavičius R, Elsakov P, Irmejs A, Berzina D, Miklaševičs E, Gardovskis J, Rebane E, Kelve M, Kładny J, Huzarski T, Gronwald J, Dębniak T, Byrski T, Stembalska A, Surdyka D, Siołek M, Szwiec M, Banaszkiewicz Z, Wiśniowski R, Kilar E, Scott RJ, Lubiński J.

Clin Genet. 2014 Aug;86(2):190-3. doi: 10.1111/cge.12251. Epub 2013 Sep 5. No abstract available.

PMID:
24032978
8.

Combined analysis of three Lynch syndrome cohorts confirms the modifying effects of 8q23.3 and 11q23.1 in MLH1 mutation carriers.

Talseth-Palmer BA, Wijnen JT, Brenne IS, Jagmohan-Changur S, Barker D, Ashton KA, Tops CM, Evans TJ, McPhillips M, Groombridge C, Suchy J, Kurzawski G; Dutch Cancer Genetics Group, Spigelman A, Møller P, Morreau HM, Van Wezel T, Lubinski J, Vasen HF, Scott RJ.

Int J Cancer. 2013 Apr 1;132(7):1556-64. doi: 10.1002/ijc.27843. Epub 2012 Oct 11.

9.

Central dopaminergic activity influences metabolic parameters in healthy men.

Brunerova L, Potockova J, Horacek J, Suchy J, Andel M.

Neuroendocrinology. 2013;97(2):132-8. doi: 10.1159/000338405. Epub 2012 Jan 28.

PMID:
22947694
10.

Polymorphism of the CD36 Gene and Cardiovascular Risk Factors in Patients with Coronary Artery Disease Manifested at a Young Age.

Rać ME, Suchy J, Kurzawski G, Kurlapska A, Safranow K, Rać M, Sagasz-Tysiewicz D, Krzystolik A, Poncyljusz W, Jakubowska K, Olszewska M, Krupa B, Chlubek D.

Biochem Genet. 2012 Feb;50(1-2):103-11. doi: 10.1007/s10528-011-9475-z. Epub 2011 Nov 24.

11.

DNA repair gene polymorphisms and risk of early onset colorectal cancer in Lynch syndrome.

Reeves SG, Meldrum C, Groombridge C, Spigelman A, Suchy J, Kurzawski G, Lubinski J, Scott RJ.

Cancer Epidemiol. 2012 Apr;36(2):183-9. doi: 10.1016/j.canep.2011.09.003. Epub 2011 Oct 5.

PMID:
21974800
12.

Host-Seeking Behavior in the Bed Bug, Cimex lectularius.

Suchy JT, Lewis VR.

Insects. 2011 Mar 7;2(1):22-35. doi: 10.3390/insects2010022.

13.

AMPD1 gene mutations are associated with obesity and diabetes in Polish patients with cardiovascular diseases.

Safranow K, Suchy J, Jakubowska K, Olszewska M, Bińczak-Kuleta A, Kurzawski G, Rzeuski R, Czyżycka E, Łoniewska B, Kornacewicz-Jach Z, Ciechanowicz A, Chlubek D.

J Appl Genet. 2011 Feb;52(1):67-76. doi: 10.1007/s13353-010-0009-x. Epub 2010 Nov 25.

14.

Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in Lynch syndrome.

Talseth-Palmer BA, Brenne IS, Ashton KA, Evans TJ, McPhillips M, Groombridge C, Suchy J, Kurzawski G, Spigelman A, Lubinski J, Scott RJ.

J Med Genet. 2011 Apr;48(4):279-84. doi: 10.1136/jmg.2010.079962. Epub 2010 Nov 19.

PMID:
21097774
15.

BRCA1 mutations and colorectal cancer in Poland.

Suchy J, Cybulski C, Górski B, Huzarski T, Byrski T, Dębniak T, Gronwald J, Jakubowska A, Wokołorczyk D, Kurzawski G, Kładny J, Jawień A, Banaszkiewicz Z, Wiśniowski R, Wandzel P, Starzewski J, Lorenc Z, Korobowicz E, Krokowicz P, Horbacka K, Lubiński J, Narod SA.

Fam Cancer. 2010 Dec;9(4):541-4. doi: 10.1007/s10689-010-9378-x.

PMID:
20862552
16.

Analysis of human CD36 gene sequence alterations in the oxidized low-density lipoprotein-binding region using denaturing high-performance liquid chromatography.

Rać ME, Suchy J, Kurzawski G, Safranow K, Jakubowska K, Olszewska M, Garanty-Bogacka B, Rać M, Poncyljusz W, Chlubek D.

Genet Test Mol Biomarkers. 2010 Aug;14(4):551-7. doi: 10.1089/gtmb.2010.0031.

PMID:
20722468
17.

Variant alleles of the CYP1B1 gene are associated with colorectal cancer susceptibility.

Trubicka J, Grabowska-Kłujszo E, Suchy J, Masojć B, Serrano-Fernandez P, Kurzawski G, Cybulski C, Górski B, Huzarski T, Byrski T, Gronwald J, Złowocka E, Kładny J, Banaszkiewicz Z, Wiśniowski R, Kowalska E, Lubinski J, Scott RJ.

BMC Cancer. 2010 Aug 11;10:420. doi: 10.1186/1471-2407-10-420.

18.

HFE gene mutations in patients with alcoholic liver disease. A prospective study from northwestern Poland.

Raszeja-Wyszomirska J, Kurzawski G, Zawada I, Suchy J, Lubinski J, Milkiewicz P.

Pol Arch Med Wewn. 2010 Apr;120(4):127-31.

19.

Combined iPLEX and TaqMan assays to screen for 45 common mutations in Lynch syndrome and FAP patients.

Dymerska D, Serrano-Fernández P, Suchy J, Pławski A, Słomski R, Kaklewski K, Scott RJ, Gronwald J, Kładny J, Byrski T, Huzarski T, Lubiński J, Kurzawski G.

J Mol Diagn. 2010 Jan;12(1):82-90. doi: 10.2353/jmoldx.2010.090063. Epub 2009 Dec 10.

20.

CHEK2 mutations and HNPCC-related colorectal cancer.

Suchy J, Cybulski C, Wokołorczyk D, Oszurek O, Górski B, Debniak T, Jakubowska A, Gronwald J, Huzarski T, Byrski T, Dziuba I, Gogacz M, Wiśniowski R, Wandzel P, Banaszkiewicz Z, Kurzawski G, Kładny J, Narod SA, Lubiński J.

Int J Cancer. 2010 Jun 15;126(12):3005-9. doi: 10.1002/ijc.25003.

21.

Dietary supplementation with S-adenosyl methionine delays the onset of motor neuron pathology in a murine model of amyotrophic lateral sclerosis.

Suchy J, Lee S, Ahmed A, Shea TB.

Neuromolecular Med. 2010 Mar;12(1):86-97. doi: 10.1007/s12017-009-8089-7. Epub 2009 Sep 16.

PMID:
19757209
22.

Clinical characteristics of tumors derived from colorectal cancer patients who harbor the tumor necrosis factor alpha-1031T/T and NOD2 3020insC polymorphism.

Kładny J, Suchy J, Kłujszo-Grabowska E, Kacperski T, Scott RJ, Kurzawski G, Lubiński J.

Cancer Epidemiol. 2009 Aug;33(2):161-3. doi: 10.1016/j.canep.2009.06.004. Epub 2009 Jul 9.

PMID:
19679065
23.

Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband.

Gronwald J, Cybulski C, Piesiak W, Suchy J, Huzarski T, Byrski T, Gorski B, Debniak T, Szwiec M, Wokolowczyk D, Matuszewski M, Sun P, Lubinski J, Narod SA.

Br J Cancer. 2009 May 5;100(9):1508-12. doi: 10.1038/sj.bjc.6605038.

24.

Haemochromatosis HFE gene polymorphisms as potential modifiers of hereditary nonpolyposis colorectal cancer risk and onset age.

Shi Z, Johnstone D, Talseth-Palmer BA, Evans TJ, Spigelman AD, Groombridge C, Milward EA, Olynyk JK, Suchy J, Kurzawski G, Lubinski J, Scott RJ.

Int J Cancer. 2009 Jul 1;125(1):78-83. doi: 10.1002/ijc.24304.

26.

MTHFR 677 C>T and 1298 A>C polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer.

Reeves SG, Meldrum C, Groombridge C, Spigelman AD, Suchy J, Kurzawski G, Lubinski J, McElduff P, Scott RJ.

Eur J Hum Genet. 2009 May;17(5):629-35. doi: 10.1038/ejhg.2008.239. Epub 2009 Jan 21.

27.

A range of cancers is associated with the rs6983267 marker on chromosome 8.

Wokolorczyk D, Gliniewicz B, Sikorski A, Zlowocka E, Masojc B, Debniak T, Matyjasik J, Mierzejewski M, Medrek K, Oszutowska D, Suchy J, Gronwald J, Teodorczyk U, Huzarski T, Byrski T, Jakubowska A, Górski B, van de Wetering T, Walczak S, Narod SA, Lubinski J, Cybulski C.

Cancer Res. 2008 Dec 1;68(23):9982-6. doi: 10.1158/0008-5472.CAN-08-1838.

28.

IGF1 is a modifier of disease risk in hereditary non-polyposis colorectal cancer.

Reeves SG, Rich D, Meldrum CJ, Colyvas K, Kurzawski G, Suchy J, Lubinski J, Scott RJ.

Int J Cancer. 2008 Sep 15;123(6):1339-43. doi: 10.1002/ijc.23668.

29.

Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk.

Suchy J, Kłujszo-Grabowska E, Kładny J, Cybulski C, Wokołorczyk D, Szymańska-Pasternak J, Kurzawski G, Scott RJ, Lubiński J.

BMC Cancer. 2008 Apr 23;8:112. doi: 10.1186/1471-2407-8-112.

30.

The -149C>T SNP within the DeltaDNMT3B gene, is not associated with early disease onset in hereditary non-polyposis colorectal cancer.

Reeves SG, Mossman D, Meldrum CJ, Kurzawski G, Suchy J, Lubinski J, Scott RJ.

Cancer Lett. 2008 Jun 28;265(1):39-44. doi: 10.1016/j.canlet.2008.02.005. Epub 2008 Mar 11.

PMID:
18336997
31.

Frequency of mutations related to hereditary haemochromatosis in northwestern Poland.

Raszeja-Wyszomirska J, Kurzawski G, Suchy J, Zawada I, Lubinski J, Milkiewicz P.

J Appl Genet. 2008;49(1):105-7. doi: 10.1007/BF03195255.

PMID:
18263976
32.

MSH6 syndrome.

Suchy J, Lubinski J.

Hered Cancer Clin Pract. 2008 Jun 15;6(2):103-4. doi: 10.1186/1897-4287-6-2-103. No abstract available.

33.

DNA testing for variants conferring low or moderate increase in the risk of cancer.

Kurzawski G, Suchy J, Cybulski C, Matyjasik J, Debniak T, Górski B, Huzarski T, Janicka A, Szymanska-Pasternak J, Lubinski J.

Hered Cancer Clin Pract. 2008 Jun 15;6(2):84-7. doi: 10.1186/1897-4287-6-2-84. No abstract available.

34.

MSH2 and MLH1 testing.

Kurzawski G, Suchy J, Lubinski J.

Hered Cancer Clin Pract. 2008 Jun 15;6(2):83. doi: 10.1186/1897-4287-6-2-83. No abstract available.

PMID:
19804602
Free PMC Article
35.

Aurora-A and Cyclin D1 polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer.

Talseth BA, Ashton KA, Meldrum C, Suchy J, Kurzawski G, Lubinski J, Scott RJ.

Int J Cancer. 2008 Mar 15;122(6):1273-7.

36.

Lack of association between genetic polymorphisms in cytokine genes and disease expression in patients with hereditary non-polyposis colorectal cancer.

Talseth BA, Meldrum C, Suchy J, Kurzawski G, Lubinski J, Scott RJ.

Scand J Gastroenterol. 2007 May;42(5):628-32.

PMID:
17454884
37.

Nationwide study of clinical and molecular features of hereditary non-polyposis colorectal cancer (HNPCC) in Latvia.

Irmejs A, Borosenko V, Melbarde-Gorkusa I, Gardovskis A, Bitina M, Kurzawski G, Suchy J, Gorski B, Gardovskis J.

Anticancer Res. 2007 Jan-Feb;27(1B):653-8.

38.

Genetic polymorphisms in xenobiotic clearance genes and their influence on disease expression in hereditary nonpolyposis colorectal cancer patients.

Talseth BA, Meldrum C, Suchy J, Kurzawski G, Lubinski J, Scott RJ.

Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2307-10.

39.

Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?

Cybulski C, Wokołorczyk D, Kładny J, Kurzawski G, Suchy J, Grabowska E, Gronwald J, Huzarski T, Byrski T, Górski B, D Ecedil Bniak T, Narod SA, Lubiński J.

Eur J Hum Genet. 2007 Feb;15(2):237-41. Epub 2006 Nov 15. Erratum in: Eur J Hum Genet. 2007 Feb;15(2):254. Kurzwaski, Grzegorz [corrected to Kurzawski, Grzegorz].

40.
41.

Frequency and nature of hMSH6 germline mutations in Polish patients with colorectal, endometrial and ovarian cancers.

Suchy J, Kurzawski G, Jakubowska K, Rać ME, Safranow K, Kładny J, Rzepka-Górska I, Chosia M, Czeszyńska B, Oszurek O, Scott RJ, Lubiński J.

Clin Genet. 2006 Jul;70(1):68-70. No abstract available.

PMID:
16813607
42.

Germline MSH2 and MLH1 mutational spectrum including large rearrangements in HNPCC families from Poland (update study).

Kurzawski G, Suchy J, Lener M, Kłujszo-Grabowska E, Kładny J, Safranow K, Jakubowska K, Jakubowska A, Huzarski T, Byrski T, Debniak T, Cybulski C, Gronwald J, Oszurek O, Oszutowska D, Kowalska E, Góźdź S, Niepsuj S, Słomski R, Pławski A, Łacka-Wojciechowska A, Rozmiarek A, Fiszer-Maliszewska Ł, Bebenek M, Sorokin D, Sasiadek MM, Stembalska A, Grzebieniak Z, Kilar E, Stawicka M, Godlewski D, Richter P, Brozek I, Wysocka B, Limon J, Jawień A, Banaszkiewicz Z, Janiszewska H, Kowalczyk J, Czudowska D, Scott RJ, Lubiński J.

Clin Genet. 2006 Jan;69(1):40-7.

PMID:
16451135
43.

CDKN2A common variant and multi-organ cancer risk--a population-based study.

Debniak T, Scott RJ, Huzarski T, Byrski T, Rozmiarek A, Debniak B, Górski B, Cybulski C, Medrek K, Mierzejewski M, Masojc B, Matyjasik J, Złowocka E, Teodorczyk U, Lener M, Klujszo-Grabowska E, Nej-Wołosiak K, Jaworowska E, Oszutowska D, Szymańska A, Szymańska J, Castaneda J, van de Wetering T, Suchy J, Kurzawski G, Oszurek O, Narod S, Lubinski J.

Int J Cancer. 2006 Jun 15;118(12):3180-2. Erratum in: Int J Cancer. 2006 Nov 15;119(10):2502.

44.

The Association of the COMT V158M Polymorphism with Endometrial/Ovarian Cancer in HNPCC Families Adhering to the Amsterdam Criteria.

Ashton KA, Meldrum CJ, McPhillips ML, Suchy J, Kurzawski G, Lubinski J, Scott RJ.

Hered Cancer Clin Pract. 2006 May 15;4(2):94-102. doi: 10.1186/1897-4287-4-2-94.

45.

Low-risk Genes and Multi-organ Cancer Risk in the Polish Population.

Debniak T, Cybulski C, Kurzawski G, Górski B, Huzarski T, Byrski T, Gronwald J, Suchy J, Masojć B, Mierzejewski M, Lener M, Teodorczyk U, Medrek K, Złowocka E, Grabowska-Kłujszo E, Nej-Wołosiak K, Szymańska A, Szymańska-Pasternak J, Matyjasik J, Wetering Tv, Jakubowska A, Oszurek O, Tołoczko-Grabarek A, Castaneda J, Scott R, Narod SA, Lubiński J.

Hered Cancer Clin Pract. 2006 Jan 15;4(1):52-5. doi: 10.1186/1897-4287-4-1-52. No abstract available.

46.

Pilot study on low penetrance breast and colorectal cancer predisposition markers in latvia.

Irmejs A, Miklasevics E, Boroschenko V, Gardovskis A, Vanags A, Melbarde-Gorkusa I, Bitina M, Suchy J, Gardovskis J.

Hered Cancer Clin Pract. 2006 Jan 15;4(1):48-51. doi: 10.1186/1897-4287-4-1-48.

47.

Age of diagnosis of colorectal cancer in HNPCC patients is more complex than that predicted by R72P polymorphism in TP53.

Talseth BA, Meldrum C, Suchy J, Kurzawski G, Lubinski J, Scott RJ.

Int J Cancer. 2006 May 15;118(10):2479-84.

48.

Prevalence of the NOD2 3020insC mutation in aggregations of breast and lung cancer.

Lener MR, Oszutowska D, Castaneda J, Kurzawski G, Suchy J, Nej-Wołosiak K, Byrski T, Huzarski T, Gronwald J, Szymańska A, Szymańska-Pasternak J, Grodzki T, Serwatowski P, Bre Borowicz G, Scott RJ, Lubiński J.

Breast Cancer Res Treat. 2006 Jan;95(2):141-5.

PMID:
16267612
49.

Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients.

Kurzawski M, Droździk M, Suchy J, Kurzawski G, Białecka M, Górnik W, Lubiński J.

Eur J Clin Pharmacol. 2005 Jul;61(5-6):389-94. Epub 2005 May 24.

PMID:
15912392
50.

NOD2 variants and the risk of malignant melanoma.

Debniak T, Kurzawski G, Huzarski T, Byrski T, Gronwald J, Debniak B, Rozmiarek A, Dziuba I, Złowocka E, Suchy J, Górski B, Cybulski C, Mierzejewski M, Masojć B, Medrek K, Oszurek O, Lubiński J.

Eur J Cancer Prev. 2005 Apr;14(2):143-6.

PMID:
15785318

Supplemental Content

Support Center